Xanthine oxidase inhibitor: Difference between revisions
Marked this version for translation |
No edit summary |
||
| Line 36: | Line 36: | ||
|- | |- | ||
|} | |} | ||
{{Pathnav|medication|frame=1}} | |||
A '''xanthine oxidase inhibitor''' is any substance that [[Enzyme inhibitor|inhibits]] the activity of [[xanthine oxidase]], an [[enzyme]] involved in [[purine metabolism]]. In [[human]]s, inhibition of xanthine oxidase reduces the production of [[uric acid]], and several [[medication]]s that inhibit xanthine oxidase are [[Indication (medicine)|indicated]] for treatment of [[hyperuricemia]] and related medical conditions including [[gout]]. Xanthine oxidase inhibitors are being investigated for management of [[reperfusion injury]]. | A '''xanthine oxidase inhibitor''' is any substance that [[Enzyme inhibitor|inhibits]] the activity of [[xanthine oxidase]], an [[enzyme]] involved in [[purine metabolism]]. In [[human]]s, inhibition of xanthine oxidase reduces the production of [[uric acid]], and several [[medication]]s that inhibit xanthine oxidase are [[Indication (medicine)|indicated]] for treatment of [[hyperuricemia]] and related medical conditions including [[gout]]. Xanthine oxidase inhibitors are being investigated for management of [[reperfusion injury]]. | ||